Avadel Pharma (AVDL) Tops Q3 EPS by 11c

Avadel Pharma (NASDAQ: AVDL) reported Q3 EPS of $0.09, $0.11 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $39.7 million versus the consensus estimate of $37.71 million.

For earnings history and earnings-related data on Avadel Pharma (AVDL) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Assurant (AIZ) is Piper Sandler's Weekly Focus Idea
• Ennis (EBF) Reports In-Line Q1 EPS